Medicine and Dentistry
Cell Line
100%
Carcinoma
100%
P16
100%
Prostate Carcinoma
100%
Messenger RNA
100%
Carcinogenesis
66%
Prostate Cancer
66%
Neoplasm
33%
Downregulation
33%
Genomic DNA
33%
Decitabine
33%
Primary Tumor
33%
Xenograft
33%
Tumor Xenograft
33%
Allele
33%
Tumor Cell Line
33%
Missense Mutation
33%
Prostate Tumor
33%
Prostate Hypertrophy
33%
Prostate Tissue
33%
Prostate Cell
33%
DU145 Cell Line
33%
Tumor Suppressor Protein
33%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoma
100%
Prostate Carcinoma
100%
Messenger RNA
100%
Neoplasm
66%
Carcinogenesis
66%
Prostate Cancer
66%
Primary Tumor
33%
Genomic DNA
33%
Prostate Tumor
33%
Decitabine
33%
Prostate Hypertrophy
33%
Tumor Suppressor Protein
33%
Biochemistry, Genetics and Molecular Biology
P16
100%
Messenger RNA
100%
Carcinogenesis
66%
Transcription
33%
Tumor Suppressor Protein
33%
Downregulation
33%
Allele
33%
Genetics
33%
Decitabine
33%
Missense Mutation
33%
Genomics
33%
Keyphrases
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
100%
P16INK4a
100%
Prostate Carcinoma
100%
Primary Carcinoma
20%
Prostate Cancer
13%
Cancer Tissue
13%
Prostate Carcinogenesis
13%
Tumor Suppressor
6%
Genomic DNA (gDNA)
6%
Tumor Cell Lines
6%
Tumor Subtype
6%
Two-cell
6%
Xenograft
6%
Tumor Tissue
6%
Prostate
6%
DU145
6%
PC-3
6%
Primary Tumor
6%
Human Tumors
6%
Transcription Regulation
6%
Reduced Expression
6%
Prostate Tumor Cells
6%
5-aza-2′-deoxycytidine
6%
Missense mutation
6%
Benign Prostatic Hyperplasia
6%
Xenograft Tumor
6%
Genetic Abnormalities
6%
Human Prostate Tissue
6%
Prostate Cells
6%
Separate Control
6%
Immunology and Microbiology
Prostate
100%
Cell Line
60%
Xenograft
40%
Downregulation
20%
Tumor Cell Line
20%
Allele
20%
Prostate Tissue
20%
Missense Mutation
20%
Prostate Cell
20%
DU145 Cell Line
20%